Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant source » significant burden (Expand Search)
Showing 841 - 860 results of 21,342 for search '(( significant decrease decrease ) OR ( significant source decrease ))*', query time: 0.32s Refine Results
  1. 841
    Regional differences in percentage changes of N06A prescribing rates during the pandemic.

    Regional differences in percentage changes of N06A prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 842
    Drugs used in addictive disorders (N07B) prescribing changes from 2014 to 2022.

    Drugs used in addictive disorders (N07B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 843
    Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (both genders).

    Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (both genders). by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 844
    Regional differences in percentage changes of N07BC drug prescribing rates during the pandemic.

    Regional differences in percentage changes of N07BC drug prescribing rates during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 845
    Regional differences in N07B drug prescribing rate percentage changes during the pandemic.

    Regional differences in N07B drug prescribing rate percentage changes during the pandemic. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 846
    Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (males).

    Drugs used in alcohol dependence (N07BB) prescribing changes from 2014 to 2022 (males). by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 847
    Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for females.

    Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for females. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 848
    Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for males.

    Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic for males. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 849
    Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic (both genders).

    Regional differences in percentage changes of N07BB drug prescribing rates during the pandemic (both genders). by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 850
    Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022.

    Drugs used in nicotine dependence (N07BA) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 851
    Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022.

    Drugs used in opioid dependence (N07BC) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 852
    Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period.

    Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 853
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 854
    Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya.

    Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 855
    Uganda: enrolment, time to IVA, mortality, admissions and readmissions.

    Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 856
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 857
    Bluetooth beacons with colour coded lanyards.

    Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 858
    Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site.

    Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 859
    PPI network analysis.

    PPI network analysis. by Du Leng (20421711)

    Published 2024
    Save to List
    Saved in:
  20. 860
    Lymphocyte proliferation assay following combination therapy with NDV.

    Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:

Search Tools: